Patent Law

NanoString Comments on Unified Patent Court Order

Retrieved on: 
Tuesday, September 19, 2023
Research, Professional Services, Patent Law, Technology, Genetics, Health Technology, Science, Legal, Biotechnology, Other Technology, Other Science, Health, Genomics, SMI, UPC, RNA, Harvard University, Bangladesh Technical Education Board, Patent, Patient, 10x Genomics, European, European Patent Convention, NanoString Technologies, United Kingdom, Genome, EU

NanoString remains steadfast in our commitment to defend the scientific community’s access to our products and researchers’ scientific freedom to select the platforms that best advance their research.

Key Points: 
  • NanoString remains steadfast in our commitment to defend the scientific community’s access to our products and researchers’ scientific freedom to select the platforms that best advance their research.
  • We do not yet have a date for those hearings.”
    Today’s order relates to European Patent 4108782B1 (the “‘782 Patent”).
  • The UPC announced that it would issue a decision in the preliminary injunction matter related to European Patent 2794928B1 (the “‘928 Patent”) on Tuesday, October 10, 2023.
  • NanoString management is reiterating its guidance for fiscal year 2023 total revenue of between $175 -$185 million.

Patent Litigation Firm Groombridge, Wu, Baughman & Stone LLP Opens Tokyo Office

Retrieved on: 
Tuesday, September 12, 2023
Other Health, General Health, Professional Services, Business, Patent Law, Other Professional Services, Science, Legal, Biotechnology, Consulting, Other Science, Health, Intellectual property, United States Court of Appeals for the Federal Circuit, Partnership, European Patent Litigation Agreement, Face, Electronics, Telecommunications, Chambers, Attorney, Greenhouse effect (United States Supreme Court), Multimedia, Lawyer, IP, University of Yamanashi, United States International Trade Commission, Jazz Photo Corp. v. United States International Trade Commission, Iranian American Bar Association, Patent Trial and Appeal Board, Inn of Court, Social justice, Japan Patent Attorneys Association, American Intellectual Property Law Association, Publication, Patent, Maxwell, Supreme court, Pleasure, IAM, Growth, Paul, Weiss, Rifkind, Wharton & Garrison, Mac, American Bar Association, American Inn, Pharmaceutical industry, Groombridge

View the full release here: https://www.businesswire.com/news/home/20230912254273/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230912254273/en/
    Photo is of prominent Japan-based patent litigator Maxwell "Mac" Fox, partner in charge of the newly launched Tokyo office of leading patent boutique law firm Groombridge, Wu, Baughman & Stone LLP.
  • Groombridge Wu was formed late last November by four preeminent patent litigators who had previously worked together for many years at Paul, Weiss, Rifkind, Wharton & Garrison LLP.
  • Groombridge Wu’s Tokyo office will focus on a single area of practice for which there is a great deal of demand.
  • The partners’ track record of success has already led to industry recognition: after only nine months, the firm has been ranked and recommended in key industry publications such as Chambers and IAM, and repeatedly identified as a 2023 “firm to watch.”
    Groombridge, Wu, Baughman & Stone LLP is a patent litigation firm.

Scramoge Technology Corrects Misleading Narrative From BMW’s Counsel Finnegan LLP

Retrieved on: 
Tuesday, September 5, 2023
Patent Law, Professional Services, Mobile, Wireless, Legal, Technology, Prejudice, Michigan Court of Appeals, Patent, Motion, District court, BMW, Automotive industry, Finnegan, Scramoge ambush

Scramoge Technology Ltd., an Irish-based company specializing in the licensing of technology in the field of wireless charging, responds to the misleading narrative ( https://www.finnegan.com/en/firm/news/finnegan-and-bmw-successfully-dism... ) released by BMW’s counsel, Finnegan, Henderson, Farabow, Garrett & Dunner LLP.

Key Points: 
  • Scramoge Technology Ltd., an Irish-based company specializing in the licensing of technology in the field of wireless charging, responds to the misleading narrative ( https://www.finnegan.com/en/firm/news/finnegan-and-bmw-successfully-dism... ) released by BMW’s counsel, Finnegan, Henderson, Farabow, Garrett & Dunner LLP.
  • When BMW and its counsel Finnegan refused to dismiss the Michigan action, Scramoge publicly filed a motion to dismiss BMW’s action with the Michigan Court.
  • In that motion Scramoge also advised Finnegan that it would be liable to Scramoge for fees and costs incurred by Scramoge for BMW and Finnegan continuing to pursue the baseless Michigan action – Finnegan never responded.
  • BMW of North America v. Scramoge Technology, 2:23-cv-10561-GAD-EAS (ED Mich)
    BMW of North America v. Scramoge Technology, Case No.

Statement on Ouster’s Ongoing Enforcement of its Patents Against Hesai

Retrieved on: 
Monday, August 28, 2023
Technology, Patent Law, Vehicle Technology, Automotive, General Automotive, Automotive Manufacturing, Professional Services, Software, Manufacturing, Hardware, ALJ, Administrative law judge, NYSE, Timeline of reactions to the Hong Kong national security law (January 2021), District court, Motion, Patent, Engineering, Administrative law, ITC, United States District Court for the Eastern District of Texas, Velodyne

The initial determination is not a decision on the merits of Ouster’s ongoing patent infringement case against Hesai.

Key Points: 
  • The initial determination is not a decision on the merits of Ouster’s ongoing patent infringement case against Hesai.
  • Ouster invented digital lidar technology following an engineering breakthrough and holds one of the largest patent families in the lidar industry.
  • Ouster's complaint sets forth how, after the market shifted toward Ouster’s digital lidar, Hesai stole Ouster’s revolutionary patented technologies and incorporated them into Hesai’s competing products.
  • The company will continue to vigorously enforce its patents and seeks to bar all infringing products from the United States.

Alnylam to Appeal Claim Construction Ruling on Two Patents Asserted Against Moderna

Retrieved on: 
Friday, August 25, 2023
Professional Services, Patent Law, Health, Legal, COVID-19, Pharmaceutical, Biotechnology, Therapy, Delaware Court of Chancery, Delaware Court, Judgement, Medication, District court, Patent, Alnylam Pharmaceuticals, RNA interference, Pharmaceutical industry, Pfizer

To date, in two separate actions against Moderna, Alnylam has sought to recover reasonable compensation for Moderna’s infringement of five Alnylam patents that cover key lipid technology embedded in Moderna’s COVID-19 Vaccine, SPIKEVAX®.

Key Points: 
  • To date, in two separate actions against Moderna, Alnylam has sought to recover reasonable compensation for Moderna’s infringement of five Alnylam patents that cover key lipid technology embedded in Moderna’s COVID-19 Vaccine, SPIKEVAX®.
  • On August 21, 2023, the Delaware Court issued an order construing certain claim terms in two of the asserted Alnylam patents.
  • In light of that order, Alnylam and Moderna have jointly agreed to final judgment of non-infringement of two of Alnylam’s patents.
  • The Delaware Court’s claim construction ruling did not impact Alnylam’s infringement contentions in its two separate suits against Pfizer.

USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.

Retrieved on: 
Tuesday, August 15, 2023
Medical Devices, Health, Patent Law, Professional Services, Legal, Patent, Patent office, Infection, United States patent law, Invention, Patient, Court, Pharmaceutical industry, Kurin

Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that the US Patent and Trademark Office has rejected the relevant claims of the ‘483 patent that Magnolia Medical asserted against Kurin.

Key Points: 
  • Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that the US Patent and Trademark Office has rejected the relevant claims of the ‘483 patent that Magnolia Medical asserted against Kurin.
  • The Patent Office determined that multiple examples of prior art render claims 1 and 24 unpatentable.
  • “We are pleased, but not surprised, to see this action from the USPTO,” said Bob Rogers, CEO of Kurin, Inc. “We strongly believe that we do not infringe the ‘483 patent, but also believe the patent was preceded by other inventions that should render it invalid.
  • This first office action suggests that the Patent Office confirms our belief.

Chemours and Honeywell Partner With Authorities in the European Union to Stop Illegal Refrigerant Imports in Greece

Retrieved on: 
Tuesday, July 18, 2023
Chemicals, Plastics, Homeland Security, Manufacturing, Oil, Gas, Public Policy, Government, Environmental Health, Energy, Maritime, Professional Services, Transport, Environment, Patent Law, Logistics, Supply Chain Management, Climate Change, Joint Interagency Task Force West, Patent, Education, CC, Hydrofluorocarbon, Intellectual property in China, Intellectual property, Collaboration, IP, Hellenic, GWP, HFO, OLAF, Hellenic Police, European, Heat, European Anti-Fraud Office, Safety, NYSE, Hydrocarbon, Patent infringement, Drug, Renewable energy, EU, Osaka Titanium Technologies, Honeywell, Chemours

Approximately 15.6 tons of suspected unauthorized refrigerants including R-1234yf used as an automotive refrigerant were seized, tested, and determined to infringe valid patents or deemed illegal in the European Union, according to Greek officials.

Key Points: 
  • Approximately 15.6 tons of suspected unauthorized refrigerants including R-1234yf used as an automotive refrigerant were seized, tested, and determined to infringe valid patents or deemed illegal in the European Union, according to Greek officials.
  • These illegal products will be safely destroyed before year-end 2023 in a process that protects workers as well as the planet.
  • Chemours collaborated with Honeywell in the operation to protect the Intellectual Property (IP) of refrigerant innovations owned by both companies and to detect and confiscate illegal F-gases.
  • These efforts are part of an ongoing commitment by Chemours and Honeywell to not only protect IP, but to defend people, businesses, communities and the planet against the ramifications of illegal import activities.

Andersen Global Continues French Expansion with Addition of Collaborating Firm PDGB

Retrieved on: 
Tuesday, June 27, 2023
Professional Services, Patent Law, Business, Legal, Insurance, Consulting, Corporate social responsibility, Private law, IP, CSR, Andersen Tax, Partner, Andersen Global, Accounting

Andersen Global broadens its footprint in Europe through a Collaboration Agreement with law firm PDGB in Paris – the fourth collaborating firm in France to join Andersen Global in the last year.

Key Points: 
  • Andersen Global broadens its footprint in Europe through a Collaboration Agreement with law firm PDGB in Paris – the fourth collaborating firm in France to join Andersen Global in the last year.
  • The addition of PDGB expands Andersen Global’s multidisciplinary platform in the country to include global mobility, valuation, and legal capabilities.
  • “Our firm looks forward to working closely with the member and collaborating firms to deliver solutions globally and better serve our clients.”
    “We are making progress in the French business market and PDGB provides another dimension with additional legal services,” said Andersen Global Chairman and Andersen CEO Mark Vorsatz.
  • Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 14,000 professionals worldwide and a presence in over 400 locations through its member firms and collaborating firms.

Vizgen Issues Open Letter to Customers and Researchers on 10x Genomics June 1, 2023 Lawsuit Announcement in Europe

Retrieved on: 
Wednesday, June 7, 2023
Neurology, Biotechnology, Oncology, Patent Law, Health, Infectious Diseases, Professional Services, Genetics, Genomics, 10x Genomics, UPC, Research, Harvard University, Sale, Friends, District court, Unified Patent Court, NanoString Technologies, Douglas v. U.S. District Court ex rel Talk America, Pharmaceutical industry

Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below open letter to customers and researchers in response to 10x Genomics, Inc. (“10x”) filing a lawsuit on June 1, 2023 with the Unified Patent Court (“UPC”) in Europe.

Key Points: 
  • Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below open letter to customers and researchers in response to 10x Genomics, Inc. (“10x”) filing a lawsuit on June 1, 2023 with the Unified Patent Court (“UPC”) in Europe.
  • Dear Customers, Researchers and Friends of Vizgen:
    We are disappointed – though not surprised – that 10x has filed another lawsuit that attempts to undermine innovation, eliminate competition and intimidate both customers and industry peers.
  • Although 10x’s UPC complaint is not yet available to us, we will keep you updated as we learn more.
  • At Vizgen, we believe that researchers should have the ability to choose the best technologies that help advance science, discovery, and human health.

Patrick M. Ryan Named “Top IP Lawyer” in California

Retrieved on: 
Wednesday, May 24, 2023
Professional Services, Legal, Patent Law, Daily Journal, Brand protection, Intellectual property, Head, Daily, E-commerce, IP, Tobacco, Bartko

Patrick M. Ryan , head of Bartko law firm’s Litigation practice and Chair of its IP and Brand Protection and Antitrust groups, named as a “ Top Intellectual Property Lawyer ” in California by the Daily Journal.

Key Points: 
  • Patrick M. Ryan , head of Bartko law firm’s Litigation practice and Chair of its IP and Brand Protection and Antitrust groups, named as a “ Top Intellectual Property Lawyer ” in California by the Daily Journal.
  • The annual list recognizes California lawyers who made the most significant contributions to intellectual property law in the last year.
  • Ryan has more than 23 years of experience successfully trying—for both plaintiffs and defendants—a wide variety of cases, including major intellectual property cases.
  • “I like to think not just outside the box, I like to use tactics from another dimension,” Ryan told the Daily Journal.